ImmunoVision

Springdale, United States Founded: 1995 • Age: 31 yrs Acquired By Erba Diagnostics
Bioreagents for diagnostic companies
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products 5 Services tracked
Competitors 10 Brand Intelligence

About ImmunoVision

ImmunoVision is a company based in Springdale (United States) founded in 1995 was acquired by Erba Diagnostics in September 2010. ImmunoVision offers products and services including Autoimmune Purified Antigens, Autoimmune Monoclonal Antibodies, Microtiter Plate Coating, Custom Purification, and Assay Development. ImmunoVision operates in a competitive market with competitors including Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience, among others.

  • Headquarter Springdale, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Erba Diagnostics

    (Sep 01, 2010)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ImmunoVision

ImmunoVision offers a comprehensive portfolio of products and services, including Autoimmune Purified Antigens, Autoimmune Monoclonal Antibodies, Microtiter Plate Coating, Custom Purification, and Assay Development.

Product name locked
Category locked
Primary

Purified antigens for autoimmune disease testing and research

Product name locked
Category locked
Locked

Monoclonal antibodies used in autoimmune diagnostics

Product name locked
Category locked
Locked

Coating service for immunoassay development

Product name locked
Category locked
Locked

Purification services for proteins and antibodies

Product name locked
Category locked
Locked

Development of immunoassays for research applications

Funding Insights of ImmunoVision

Premium access

Detailed funding history for ImmunoVision

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in ImmunoVision

ImmunoVision has secured backing from 1 investor. Prominent investors backing the company include Erba Diagnostics.

All
Investor Description Founded Year Domain Location
Diagnostic assays and instruments are developed for medical diagnostics.
Locked Locked Locked
Premium access

Investor details for ImmunoVision

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ImmunoVision

Investments
Premium access

Investment portfolio details for ImmunoVision

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - ImmunoVision

Premium access

Detailed financials for ImmunoVision

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Immunovision Comparisons

ImmunoVision Primary company
Description
Bioreagents for diagnostic companies
Location
Springdale, United States
Founded Year
1995
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for ImmunoVision

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ImmunoVision

ImmunoVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Biological reagents and antibodies are developed for life science research.
Locked Locked Locked
Developer of cell culture media and ancillary reagents for life science research
Locked Locked Locked
Proteins, antibodies, and molecular tools are manufactured for research applications.
Locked Locked Locked
Research services, reagents, and kits for biotech applications are provided.
Locked Locked Locked
Molecular diagnostic device and kits
Locked Locked Locked
Molecular biology reagents and kits are supplied for research applications.
Premium access

Detailed competitors of ImmunoVision

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Immunovision

Premium access

Complete news archive for ImmunoVision

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ImmunoVision

ImmunoVision was founded in 1995.

ImmunoVision is headquartered in Springdale, United States. It is registered at Springdale, Arkansas, United States.

ImmunoVision was founded in 1995 and is based in Springdale, United States. Bioreagents are produced and supplied to the diagnostic sector, focusing on autoimmune applications such as purified antigens, monoclonal antibodies, polyclonal antibodies, ENA Ouchterlony components, extracts, and acetone tissue powders. For infectious diseases, purified antigens, monoclonal antibodies, and polyclonal antibodies are also offered. Operations are conducted as a subsidiary of ERBA Diagnostics Inc.

ImmunoVision's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.

ImmunoVision offers Autoimmune Purified Antigens, Autoimmune Monoclonal Antibodies, Microtiter Plate Coating, Custom Purification, and Assay Development.

ImmunoVision has 1 investor. Key investors include Erba Diagnostics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available